Aspirin to prevent stroke after aortic arch repair
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether taking aspirin after a specific type of aortic surgery can help prevent strokes. If you've had a total endovascular aortic arch repair with branch vessel reconstruction, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a type B or non-A non-B aortic dissection or a thoracic aortic aneurysm
- You have had a total endovascular aortic arch repair with reconstruction of the supra-arch branch arteries at a participating center
- You are willing to sign a consent form to participate
- You have no known allergies to aspirin or NSAIDs (like ibuprofen)
- You do not have active bleeding or a bleeding tendency
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special stent graft for people with a type B aortic dissection that needs a new blood flow path to the left subclavian artery. The device is placed in the aortic arch to repair the tear and keep blood flowing normally.
This trial tests whether taking aspirin alone is as safe and effective as taking aspirin with warfarin after a TAVR procedure for severe aortic regurgitation. It is for people who do not need long-term blood thinners for other conditions.
This study tests a special approach during surgery for a type of aortic dissection (a tear in the main artery) to lower the chance of new stroke or brain damage. It aims to improve recovery after emergency heart surgery.
This trial tests a new stent system to help repair the aorta after initial surgery for type A aortic dissection. It may help promote better healing of the remaining damaged section.
This trial compares aspirin and clopidogrel (two blood-thinning medicines) after TAVR to see which is safer or more effective for preventing clots. You may be able to join if you recently had a TAVR for severe aortic valve narrowing and can follow the study plan.
This study tests whether an “add-on” anti-inflammatory approach can help after surgery for certain problems affecting the aorta (the body’s main artery) soon after symptoms begin. It may be designed to reduce inflammation-related complications in people who are treated quickly and can join follow-up.
Hear when a new Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.